Not admitted · Outside the five areas

Republished 'classic' essay titled 'Theranos Was a Good Investment [and still is!]'. The author asserts, explicitly not just as clickbait, that the technology Theranos actually built (a fingerstick single-test device) is undervalued and a hot opportunity for health-tech investors, absent the imprisoned-founder problem.

Outside the five area definitions in areas.json: not a regulatory decision, trial outcome, company or market outcome, payer or policy decision, or practice adoption about drugs, devices or treatments in psychiatry, or about payment for and access to them. The registry applies the same test when it consolidates proposed events.